NEW YORK, Feb. 22, 2022 /PRNewswire/ -- As per analysts at Zion Market Research, the global cancer drugs market was capitalized at almost USD 155.12 Billion in 2020 and is anticipated to create income of almost USD 292.80 Billion by 2028, developing at a CAGR of almost 9.5% from 2021 to 2028.
Read Market Research Report "Cancer Drugs Market By Therapy (Immunotherapy, Targeted Therapy, Chemotherapy, Hormone Therapy and Others), By Cancer Type (For Breast Cancer, Blood Cancer, Gastrointestinal Cancer, Prostate Cancer, Skin Cancer, Lung Cancer and Other): Global Industry Perspective, Comprehensive Analysis And Forecast, 2021-2028."
The cancer drugs market has undergone a fall due to the various shutdowns and government orders as a view to contain the spread of COVID 19. The entire pharmaceutical industry was on a halt during stringent lockdown as all the attention shifted drastically on COVID 19. The restrictions imposed by various nations to contain COVID had stopped the supply chains and exchange of significant medical ingredients across countries, causing a downfall in the market. The pharmaceutical industry has now shifted all the investment, research to the focus of COVID19. Cancer industry Chemotherapy depends on the spending having made on R&D, but post pandemic, the spending has shifted for COVID.
Growing Research and Development On Targeted & Biological Drug Treatments For The Cure Of Cancer To Have Positive Effect On Cancer Drugs Market:
"Global cancer drugs market is majorly boosted by increasing cases of target disease such as breast cancer, lung cancer, and cervical cancer all over the globe," as per analysts at Zion Market Research. Other major boosting factors are growing research and development on targeted & biological drug treatments for the cure of cancer. On the other hand, stringent regulatory policies and the high cost of drug development paired along with the potential of failure are the primary limitations that might hinder the development of the cancer drugs market.
Nevertheless, huge spending in anti-cancer drugs research paired with rising aim on personalized medicine all over the world is likely to disclose the new growth opportunities for cancer drugs market in the years to come. Rising elderly population in developed as well as developing nation is also one of the major reasons responsible for the development of cancer drugs market. In addition, various mergers and acquisitions by market players are also set to bolster the cancer drugs market. For example, in June 2018, Bayer successfully concluded the acquirement of Monsanto. Similarly, in May 2018, Boehringer Ingelheim (the second biggest animal health firm in the world) boosted its investment in China by extending the Asian Veterinary R&D (Research & Development) hub to improve its innovation and research capacity.
Get More Insight before Buying @: https://www.zionmarketresearch.com/inquiry/cancer-drugs-market
North America Likely To Stay The Dominating Area In The Global Cancer Drugs Market In The Years To Come:
Europe, North America, Latin America, Asia-Pacific, and the Middle East & Africa are major regional sections in the global cancer drugs market. North America is likely to stay the dominating area in the years to come. Requirement for cancer drugs was uppermost in North America particularly in the U.S. Therefore, Asia Pacific is likely to be the moderate developing area in cancer drugs market in the years to come. In addition to this, the Latin America and Middle East & Africa are also likely to display moderate development for cancer drugs market in the coming years.
Report Scope:
Report Attribute | Details |
Market size value in 2020 | USD 155.12 Billion |
Revenue forecast in 2028 | USD 292.80 Billion |
Growth Rate | CAGR of almost 9.5% 2021-2028 |
Base Year | 2021 |
Historic Years | 2016 - 2020 |
Forecast Years | 2021 - 2028 |
Segments Covered | By Product Type, By Application, and By End Use |
Forecast Units | Value (USD Billion), and Volume (Units) |
Quantitative Units | Revenue in USD million/billion and CAGR from 2021 to 2028 |
Regions Covered | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World |
Countries Covered | U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others |
Companies Covered | GlaxoSmithKline, Bayer, Sanofi, Novartis, Amgen, Pfizer, Bristol-Myers Squibb, Merck, Ariad Pharmaceuticals, Celgene Corporation, Hoffmann-La Roche Ltd, Eli Lilly, Johnson and Johnson, Boehringer Ingelheim GmbH, and Teva Pharmaceuticals among others |
Report Coverage | Market growth drivers, restraints, opportunities, Porter's five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis. |
Customization Scope | Avail customized purchase options to meet your exact research needs. https://www.zionmarketresearch.com/buynow/su/cancer-drugs-market |
Request Pre and Post COVID-19 Impact Analysis on Businesses: https://www.zionmarketresearch.com/custom/490?covid19=true
The Cancer Drugs Market is segmented as follows:
Cancer Drugs Market: By Cancer Therapy Outlook (2021-2028)
- Immunotherapy
- Targeted Therapy
- Chemotherapy
- Hormone therapy
Cancer Drugs Market: By Cancer Type Outlook (2021-2028)
- Breast Cancer
- Blood Cancer
- Gastrointestinal Cancer
- Prostate Cancer
- Skin Cancer
- Lung Cancer
Cancer Drugs Market: By Region Outlook (2021-2028)
North America
- The U.S.
- Canada
Europe
- France
- The UK
- Spain
- Germany
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
Get Free Sample Report with All Related Graphs & Charts (with COVID 19 Impact Analysis): https://www.zionmarketresearch.com/sample/cancer-drugs-market
List of Key Players of Cancer Drugs Market:
- GlaxoSmithKline
- Bayer
- Sanofi
- Novartis
- Amgen
- Pfizer
- Bristol-Myers Squibb
- Merck
- Ariad Pharmaceuticals
- Celgene Corporation
- Hoffmann-La Roche Ltd
- Eli Lilly
- Johnson and Johnson
- Boehringer Ingelheim GmbH
- Teva Pharmaceuticals
- others
Press Release For Cancer Drugs Market: https://www.zionmarketresearch.com/news/global-cancer-drugs-market
Browse Other Related Research Reports from Zion Market Research
- Healthcare Contract Development and Manufacturing Organization Market: The global Healthcare Contract Development and Manufacturing Organization Market accrued earnings worth approximately 207.2 (USD Billion) in 2020 and is predicted to gain revenue of about 390.1 (USD Billion) by 2028, is set to record a CAGR of nearly 8.7% over the period from 2021 to 2028.
- Stem Cell Therapy Market: The global Stem Cell Therapy Market accrued earnings worth approximately 182 (USD Million) in 2020 and is predicted to gain revenue of about 800 (USD Million) by 2028, is set to record a CAGR of nearly 20.1% over the period from 2021 to 2028
- Immuno-Oncology Clinical Trials Market: The global Immuno-Oncology Clinical Trials Market accrued earnings worth approximately 5.4 (USD Billion) in 2020 and is predicted to gain revenue of about 15.6 (USD Billion) by 2028, is set to record a CAGR of nearly 13.7% over the period from 2021 to 2028.
Directly Purchase a Copy of the Report @ https://www.zionmarketresearch.com/buynow/su/cancer-drugs-market
Browse through Zion Market Research's coverage of the Global Healthcare Industry
About Us
Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client's needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us-after all-if you do well, a little of the light shines on us.
Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com/
Blog - https://zmrblog.com/
Logo: https://mma.prnewswire.com/media/1605489/Zion_Market_Research_Logo.jpg
